An inverse agonist of ERRγ, GSK5182, increases iodine uptake and enhances membrane localization of NIS in anaplastic thyroid cancer cells [46]. This evidence concerns the gene ESRRG and thyroid gland undifferentiated (anaplastic) carcinoma.